Slate Bio
company
About
Slate Bio is an immunotherapeutics development company that develops therapeutic solutions for autoimmune diseases.
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $1.75M
- Industries
- Biotechnology,Medical,Therapeutics
- Founded date
- Jan 1, 2020
- Operating Status
- Active
Slate Bio is an immunotherapeutics development company that develops therapies that restore the body's natural immunological response in different diseases using bifunctional IL233 cytokine, thereby providing users with an independent synergistic pathway that has greater tissue selectivity and improved pharmacodynamics.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1.75M
Slate Bio has raised a total of
$1.75M
in funding over 2 rounds. Their latest funding was raised on
Jan 19, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 19, 2021 | Seed | $1.75M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Slate Bio is funded by 1 investors.
VTC Seed Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
VTC Seed Fund
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
